Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Thromboembolism of Vein VTE in Colorectal Cancer 1 Ovarian Neoplasms 1 Kidney Neoplasms 1 Fatigue 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1

Interventions

Sunitinib 26 Everolimus 20 Bevacizumab 19 aldesleukin 18 Sorafenib 16 Nivolumab 16 Interleukin-2 14 pembrolizumab 13 Peripheral Blood Stem Cell Transplantation 13 fludarabine phosphate 12 Radiotherapy 12 Interferon-alpha 12 Cyclophosphamide 12 Radiosurgery 11 Filgrastim 11 Blood Specimen Collection 11 Ipilimumab 10 Gemcitabine 10 Axitinib 9 Surveys and Questionnaires 7 Gene Expression Profiling 7 Cryosurgery 7 temsirolimus 6 pazopanib 6 Surgical Procedures, Operative 6 durvalumab 5 cabozantinib 5 atezolizumab 5 Mycophenolic Acid 5 Immunohistochemistry 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Kidney Neoplasms × isoquercitrin × Clear all

NCT02446795 2017-01-18

QUASAR

Consorzio Oncotech

Phase 1/2 Unknown

Carcinoma, Renal Cell, Fatigue, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡